SCHEMBL29357466

SCHEMBL29357466

O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCC[C@H](NC(=O)CCN1C(=O)C=CC1=O)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.64
▸ FOLH1 Q04609 9/20 0.62
▸ CAPN1 P07384 2/20 0.52
▸ CA12 O43570 1/20 0.49
▸ CA1 P00915 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ CNR1 P21554 2/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ ABL1 P00519 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ IDE P14735 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ RIN1 Q13671 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29434690 1.00 TDP1 (0.64) TDP1FOLH1CAPN1CA12CA1
SCHEMBL10172392 1.00 TDP1 (0.64) TDP1FOLH1CAPN1CA12CA1
SCHEMBL19255498 0.97 TDP1 (0.64) TDP1FOLH1CAPN1CA12CA1
SCHEMBL9807479 0.91 TDP1 (0.77) TDP1FOLH1CAPN1CA12CA1
SCHEMBL24858268 0.90 TDP1 (0.57) TDP1FOLH1CAPN1CA12CA1
SCHEMBL24858269 0.90 TDP1 (0.57) TDP1FOLH1CAPN1CA12CA1
SCHEMBL12809811 0.86 TDP1 (0.73) TDP1FOLH1CAPN1CA12CA1
SCHEMBL5072668 0.86 TDP1 (0.64) TDP1FOLH1CAPN1CA12CA1
SCHEMBL19169721 0.86 TDP1 (0.63) TDP1FOLH1CAPN1CA12CA1
SCHEMBL10044328 0.85 TDP1 (0.72) TDP1FOLH1CAPN1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154852-A1 ANTIBODY BARCODED BEADS AND USES THEREOF CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-08-17 — — WO claimed
CN-119998887-A Methods and systems for predicting HLA epitopes 百欧恩泰美国公司 2025-05-13 — — CN disclosed
CN-119864090-A Methods and systems for predicting HLA class II specific epitopes and characterizing CD4+ T cells 百欧恩泰美国公司 2025-04-22 — — CN disclosed
CN-119698427-A Methods and systems for predicting HLA class II specific epitopes and characterizing CD4+ T cells 百欧恩泰美国公司 2025-03-25 — — CN disclosed
WO-2025013907-A1 USE OF SPIROOXINDOLE OXIRANE DERIVATIVE FOR MODIFYING PEPTIDE AND/OR PROTEIN OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) 2025-01-16 — — WO disclosed
CN-113474840-B Methods and systems for predicting HLA class II specific epitopes and characterizing CD4+ T cells 百欧恩泰美国公司 2024-12-17 — — CN disclosed
US-12152256-B2 Nucleotide transient binding for sequencing methods Life Technologies Corporation (US) 2024-11-26 — — US disclosed
EP-4463567-A1 METHODS AND COMPOSITIONS FOR TRANSCRIPTOME ANALYSIS JumpCode Genomics, Inc. (US) 2024-11-20 — — EP disclosed
CN-113403293-B Polymerase compositions and methods of making and using the same 生命技术公司 2024-08-16 — — CN disclosed
CN-112980827-B Immobilized glucose oxidase of metal organic framework material and preparation method and application thereof 江苏大学京江学院 2024-04-09 — — CN disclosed
CN-116693695-A HLA-based methods and compositions and uses thereof 百欧恩泰美国公司 2023-09-05 — — CN disclosed
WO-2023154852-A1 ANTIBODY BARCODED BEADS AND USES THEREOF CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-08-17 — — WO disclosed
WO-2023137292-A1 METHODS AND COMPOSITIONS FOR TRANSCRIPTOME ANALYSIS Jumpcode Genomics, Inc. (US) 2023-07-20 — — WO disclosed
CN-110809716-B HLA-based methods and compositions and uses thereof 百欧恩泰美国公司 2023-07-07 — — CN disclosed
CN-116218815-A Polymerase compositions and kits and methods of use and manufacture thereof 生命技术公司 2023-06-06 — — CN disclosed
EP-4090766-A1 METHODS OF TARGETED SEQUENCING Jumpcode Genomics, Inc. (US) 2022-11-23 — — EP disclosed
EP-4090760-A1 METHODS OF SAMPLE NORMALIZATION Jumpcode Genomics, Inc. (US) 2022-11-23 — — EP disclosed
US-20220026427-A1 CELL BASED ASSAYS AND KITS FOR ASSESSING SERUM CHOLINERGIC RECEPTOR ACTIVITY CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) 2022-01-27 — — US disclosed
Send feedback